(Q34528217)

English

Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jong-Hoon Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Nancy R Slifman

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sharon K Gershon

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Evelyne T Edwards

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

William D Schwieterman

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jeffrey N Siegel

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Robert P Wise

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

S Lori Brown

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

John N Udall

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

M Miles Braun

10

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

2565-2570

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

The divergent role of tumor necrosis factor receptors in infectious diseases

1 reference

https://api.crossref.org/works/10.1002%2FART.10583

21 January 2018

Tumor necrosis factor-alpha plays a role in host defense against Histoplasma capsulatum

1 reference

https://api.crossref.org/works/10.1002%2FART.10583

21 January 2018

Further observations on histoplasmin sensitivity in the United States

1 reference

https://api.crossref.org/works/10.1002%2FART.10583

21 January 2018

Immunological aspects of fungal pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FART.10583

21 January 2018

Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions

1 reference

https://api.crossref.org/works/10.1002%2FART.10583

21 January 2018

Opportunistic infection during treatment with low dose methotrexate

1 reference

https://api.crossref.org/works/10.1002%2FART.10583

21 January 2018

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

https://api.crossref.org/works/10.1002%2FART.10583

21 January 2018

Identifiers

10.1002/ART.10583

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34528217&oldid=2050742603"